» Articles » PMID: 36812501

Pleiotropic Effects of GLP-1 Receptor Agonists on Peripheral Artery Disease: Is There Any Hope?

Overview
Specialty Endocrinology
Date 2023 Feb 22
PMID 36812501
Authors
Affiliations
Soon will be listed here.
Citing Articles

GLP-1 receptor agonists' impact on cardio-renal outcomes and mortality in T2D with acute kidney disease.

Pan H, Chen J, Chen H, Yeh F, Sun C, Huang T Nat Commun. 2024; 15(1):5912.

PMID: 39003287 PMC: 11246471. DOI: 10.1038/s41467-024-50199-y.


Challenges and opportunities in the management of type 2 diabetes in patients with lower extremity peripheral artery disease: a tailored diagnosis and treatment review.

Mahe G, Aboyans V, Cosson E, Mohammedi K, Sarlon-Bartoli G, Laneelle D Cardiovasc Diabetol. 2024; 23(1):220.

PMID: 38926722 PMC: 11210102. DOI: 10.1186/s12933-024-02325-9.


Liraglutide for Lower Limb Perfusion in People With Type 2 Diabetes and Peripheral Artery Disease: The STARDUST Randomized Clinical Trial.

Caruso P, Maiorino M, Longo M, Porcellini C, Matrone R, Selvaggio L JAMA Netw Open. 2024; 7(3):e241545.

PMID: 38470420 PMC: 10933706. DOI: 10.1001/jamanetworkopen.2024.1545.


The Metabolic Characteristics of Patients at the Risk for Diabetic Foot Ulcer: A Comparative Study of Diabetic Patients with and without Diabetic Foot.

Li X, Wen S, Dong M, Yuan Y, Gong M, Wang C Diabetes Metab Syndr Obes. 2023; 16:3197-3211.

PMID: 37867628 PMC: 10590077. DOI: 10.2147/DMSO.S430426.


Focus on Prevention: Peripheral Arterial Disease and the Central Role of the Cardiologist.

Fioretti V, Gerardi D, Giugliano G, Di Fazio A, Stabile E J Clin Med. 2023; 12(13).

PMID: 37445373 PMC: 10342387. DOI: 10.3390/jcm12134338.